Animal testing, long used in science, is considered outdated, cruel and unnecessary. Every year, millions of animals are subjected to painful experiments in laboratories, often resulting in permanent ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM ESTCompany ParticipantsRamy Farid - CEO, President ...

Chemical toxicity evaluation is vital in the medical, industrial, and agricultural sectors to ensure rigorous safety testing and to prevent harmful ...

A cell model that replicates the structure and function of the human intestine has been developed, creating an evaluation platform capable of more accurately predicting adverse effects of new drugs.

A genome-wide cfDNA methylation enrichment method (cfMeDIP-seq) enables response monitoring using plasma alone, avoiding ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024--2032. Growth is underpinned by ...

Pittcon 2026 (held in San Antonio, TX) will present a session focusing on advances in the detection and characterization of per- and polyfluoroalkyl substances (PFAS). PFAS persist in water, soil, and ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the appointment of Dr. Arumugham ...

Microsoft researchers have developed On-Policy Context Distillation (OPCD), a training method that permanently embeds ...

This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...

Drs Kathy Miller and Sunil Badve discuss how HER2 testing has evolved over time as the need for that clinical testing has shifted, including assay limits, biology, and clinical impact.

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...